Alkan S - Search Results

1

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.

Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B. Querec T, et al. Among authors: alkan s. J Exp Med. 2006 Feb 20;203(2):413-24. doi: 10.1084/jem.20051720. Epub 2006 Feb 6. J Exp Med. 2006. PMID: 16461338 Free PMC article.

2

Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus.

Kwissa M, Amara RR, Robinson HL, Moss B, Alkan S, Jabbar A, Villinger F, Pulendran B. Kwissa M, et al. Among authors: alkan s. J Exp Med. 2007 Oct 29;204(11):2733-46. doi: 10.1084/jem.20071211. Epub 2007 Oct 22. J Exp Med. 2007. PMID: 17954572 Free PMC article.

3

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

Gorden KB, Gorski KS, Gibson SJ, Kedl RM, Kieper WC, Qiu X, Tomai MA, Alkan SS, Vasilakos JP. Gorden KB, et al. Among authors: alkan ss. J Immunol. 2005 Feb 1;174(3):1259-68. doi: 10.4049/jimmunol.174.3.1259. J Immunol. 2005. PMID: 15661881

4

Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides.

Gorden KK, Qiu XX, Binsfeld CC, Vasilakos JP, Alkan SS. Gorden KK, et al. Among authors: alkan ss. J Immunol. 2006 Nov 15;177(10):6584-7. doi: 10.4049/jimmunol.177.10.6584. J Immunol. 2006. PMID: 17082568

5

Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.

Gorden KK, Qiu X, Battiste JJ, Wightman PP, Vasilakos JP, Alkan SS. Gorden KK, et al. Among authors: alkan ss. J Immunol. 2006 Dec 1;177(11):8164-70. doi: 10.4049/jimmunol.177.11.8164. J Immunol. 2006. PMID: 17114492

6

Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists.

Gorski KS, Waller EL, Bjornton-Severson J, Hanten JA, Riter CL, Kieper WC, Gorden KB, Miller JS, Vasilakos JP, Tomai MA, Alkan SS. Gorski KS, et al. Among authors: alkan ss. Int Immunol. 2006 Jul;18(7):1115-26. doi: 10.1093/intimm/dxl046. Epub 2006 May 25. Int Immunol. 2006. PMID: 16728430

7

Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides.

Akdis CA, Kussebi F, Pulendran B, Akdis M, Lauener RP, Schmidt-Weber CB, Klunker S, Isitmangil G, Hansjee N, Wynn TA, Dillon S, Erb P, Baschang G, Blaser K, Alkan SS. Akdis CA, et al. Among authors: alkan ss. Eur J Immunol. 2003 Oct;33(10):2717-26. doi: 10.1002/eji.200323329. Eur J Immunol. 2003. PMID: 14515255 Free article.

8

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.

Brinkmann V, Geiger T, Alkan S, Heusser CH. Brinkmann V, et al. Among authors: alkan s. J Exp Med. 1993 Nov 1;178(5):1655-63. doi: 10.1084/jem.178.5.1655. J Exp Med. 1993. PMID: 8228812 Free PMC article.

9

Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.

Ghosh TK, Mickelson DJ, Fink J, Solberg JC, Inglefield JR, Hook D, Gupta SK, Gibson S, Alkan SS. Ghosh TK, et al. Among authors: alkan ss. Cell Immunol. 2006 Sep;243(1):48-57. doi: 10.1016/j.cellimm.2006.12.002. Epub 2007 Jan 23. Cell Immunol. 2006. PMID: 17250816

10

TLR7 agonist 852A inhibition of tumor cell proliferation is dependent on plasmacytoid dendritic cells and type I IFN.

Inglefield JR, Dumitru CD, Alkan SS, Gibson SJ, Lipson KE, Tomai MA, Larson CJ, Vasilakos JP. Inglefield JR, et al. Among authors: alkan ss. J Interferon Cytokine Res. 2008 Apr;28(4):253-63. doi: 10.1089/jir.2007.0097. J Interferon Cytokine Res. 2008. PMID: 18439103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters